Symptom-centric view
Gastrooesophageal reflux disease
Substances reporting Gastrooesophageal reflux disease disproportionately — ranked by ROR.
showing 4 of 4
| Substance ↓ | ROR [95% CI] | Reports | Category | Label |
|---|---|---|---|---|
tretinoin Retin-A · Atralin | 10.2 [9.1–11.4] | 320 | injectables | new |
tirzepatide Mounjaro · Zepbound | 2.5 [2.3–2.6] | 1,303 | glp-1 | new |
nicotinamide Niacinamide | 45.9 [41.0–51.3] | 358 | longevity | new |
| 3.8 [3.5–4.1] | 693 | algemeen | new |
ROR = reporting odds ratio vs. the full FAERS corpus. A signal is not a cause. Source: openFDA (FAERS).